Lantern Pharma Inc. (LTRN) › Operating IncomeLantern Pharma Inc. (LTRN) — Operating IncomeAnnual figures by period end, from SEC filings.2021-12-31: -$12.59M2022-12-31: -$14.43M2023-12-31: -$17.88M2024-12-31: -$22.22M2025-12-31: -$17.98M-$17.98M2021-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$17.98M—2026-03-30From 2025-01-012024-12-31-$22.22M—2026-03-30From 2024-01-012023-12-31-$17.88M—2025-03-27From 2023-01-012022-12-31-$14.43M—2024-03-18From 2022-01-012021-12-31-$12.59M—2023-03-20From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)